96 related articles for article (PubMed ID: 11443925)
1. [Interaction of topotecan--a DNA topoisomerase inhibitor--with dual-stranded polydeoxyribonucleotides. I. Dimerization of topotecan in solution].
Strel'tsov SA; Grokhovskiĭ SL; Kudelina IA; Oleĭnikov VA; Zhuze AL
Mol Biol (Mosk); 2001; 35(3):432-41. PubMed ID: 11443925
[TBL] [Abstract][Full Text] [Related]
2. [Interaction of topotecan--a DNA topoisomerase I inhibitor--with dual-stranded polydeoxyribonucleotides. II. Formation of a complex containing several DNA molecules in the presence of topotecan].
strel'tsov SA; Mikheĭkin AL; Nechipurenko IuD
Mol Biol (Mosk); 2001; 35(3):442-50. PubMed ID: 11443926
[TBL] [Abstract][Full Text] [Related]
3. Interaction of clinically important human DNA topoisomerase I poison, topotecan, with double-stranded DNA.
Streltsov S; Oleinikov V; Ermishov M; Mochalov K; Sukhanova A; Nechipurenko Y; Grokhovsky S; Zhuze A; Pluot M; Nabiev I
Biopolymers; 2003; 72(6):442-54. PubMed ID: 14587067
[TBL] [Abstract][Full Text] [Related]
4. [Interaction of topotecan-a DNA topoisomerase I inhibitor-with dual-stranded polydeoxyribonucleotides. V. Topotecan is able to cause single- and double-strand breaks in ring superhelical DNA in the absence of enzyme].
Grokhovskiĭ SL; Strel'tsov SA; Zhuze AL
Mol Biol (Mosk); 2003; 37(6):1045-54. PubMed ID: 14714500
[TBL] [Abstract][Full Text] [Related]
5. [Interaction of topotecan, DNA topoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. III. Binding at the minor groove].
Strel'tsov SA; Mikheĭkin AL; Grokhovskiĭ SL; Oleĭnikov VA; Zhuze AL
Mol Biol (Mosk); 2002; 36(3):511-24. PubMed ID: 12068638
[TBL] [Abstract][Full Text] [Related]
6. [Interaction of topotecan, DNA topoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. 4. Topotecan binds preferably to the GC base pairs of DNA].
Strel'tsov SA; Mikheĭkin AL; Grokhovskiĭ SL; Oleĭnikov VA; Kudelina IA; Zhuze AL
Mol Biol (Mosk); 2002; 36(5):912-30. PubMed ID: 12391856
[TBL] [Abstract][Full Text] [Related]
7. Action models for the antitumor drug camptothecin: formation of alkali-labile complex with DNA and inhibition of human DNA topoisomerase I.
Streltsov SA
J Biomol Struct Dyn; 2002 Dec; 20(3):447-54. PubMed ID: 12437383
[TBL] [Abstract][Full Text] [Related]
8. Structural spectroscopy and dynamics of inter- and intramolecular H-bonding interactions of topotecan, a potent anticancer drug, in organic solvents and in aqueous solution.
di Nunzio MR; Wang Y; Douhal A
J Phys Chem B; 2012 Jun; 116(25):7522-30. PubMed ID: 22662747
[TBL] [Abstract][Full Text] [Related]
9. Binding of topotecan to a nicked DNA oligomer in solution.
Bocian W; Kawecki R; Bednarek E; Sitkowski J; Williamson MP; Hansen PE; Kozerski L
Chemistry; 2008; 14(9):2788-94. PubMed ID: 18214879
[TBL] [Abstract][Full Text] [Related]
10. Structure and spectroscopy of oxyluciferin, the light emitter of the firefly bioluminescence.
Naumov P; Ozawa Y; Ohkubo K; Fukuzumi S
J Am Chem Soc; 2009 Aug; 131(32):11590-605. PubMed ID: 19722653
[TBL] [Abstract][Full Text] [Related]
11. Antitumour drugs impede DNA uncoiling by topoisomerase I.
Koster DA; Palle K; Bot ES; Bjornsti MA; Dekker NH
Nature; 2007 Jul; 448(7150):213-7. PubMed ID: 17589503
[TBL] [Abstract][Full Text] [Related]
12. Topotecan lactone selectively binds to double- and single-stranded DNA in the absence of topoisomerase I.
Yao S; Murali D; Seetharamulu P; Haridas K; Petluru PN; Reddy DG; Hausheer FH
Cancer Res; 1998 Sep; 58(17):3782-6. PubMed ID: 9731484
[TBL] [Abstract][Full Text] [Related]
13. [Killing and proapoptotic effects of topoisomerase I inhibitor on K562 cells].
Chen XQ; Wan YF; Bai QX; Cao YX
Ai Zheng; 2002 Apr; 21(4):356-9. PubMed ID: 12452010
[TBL] [Abstract][Full Text] [Related]
14. Topotecan-induced alterations in the amount and stability of human DNA topoisomerase I in solid tumor cell lines.
Devy J; Wargnier R; Pluot M; Nabiev I; Sukhanova A
Anticancer Res; 2004; 24(3a):1745-51. PubMed ID: 15274350
[TBL] [Abstract][Full Text] [Related]
15. Activity of Topotecan toward the DNA/Topoisomerase I Complex: A Theoretical Rationalization.
Bali SK; Marion A; Ugur I; Dikmenli AK; Catak S; Aviyente V
Biochemistry; 2018 Mar; 57(9):1542-1551. PubMed ID: 29412654
[TBL] [Abstract][Full Text] [Related]
16. Solvent effects on the valence UV-vis absorption spectra of topotecan anticancer drug in aqueous solution at room temperature: a nanoseconds time-scale TD-DFT/MD computational study.
Zazza C; Coletta A; Sanna N; Chillemi G; Mancini G; Desideri A
J Phys Chem B; 2010 May; 114(20):6770-8. PubMed ID: 20438088
[TBL] [Abstract][Full Text] [Related]
17. Structural photodynamic behavior of topotecan, a potent anticancer drug, in aqueous solutions at different pHs.
di Nunzio MR; Wang Y; Douhal A
J Phys Chem B; 2012 Jul; 116(28):8182-90. PubMed ID: 22712701
[TBL] [Abstract][Full Text] [Related]
18. Electronic absorption study on acid-base equilibria for some keto and thioketo pyrimidine derivatives. Experimental and theoretical evidence of enolization and solute-solvent interactions.
Kiliç H
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Aug; 67(5):1210-9. PubMed ID: 17126068
[TBL] [Abstract][Full Text] [Related]
19. The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell line.
Zhang J; Cheng C; He CL; Zhou YJ; Cao Y
Cancer Invest; 2008 Jun; 26(5):456-63. PubMed ID: 18568767
[TBL] [Abstract][Full Text] [Related]
20. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs.
Lansiaux A; Léonce S; Kraus-Berthier L; Bal-Mahieu C; Mazinghien R; Didier S; David-Cordonnier MH; Hautefaye P; Lavielle G; Bailly C; Hickman JA; Pierré A
Mol Pharmacol; 2007 Aug; 72(2):311-9. PubMed ID: 17494837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
